Bristol-Myers Squibb’s share price has been going through the roof due to the company’s emergence as a leader in the field of immuno-oncology. This big pharma’s high-flying days might be numbered, however. Here’s why.
Bristol-Myers Squibb’s share price has been going through the roof due to the company’s emergence as a leader in the field of immuno-oncology. This big pharma’s high-flying days might be numbered, however. Here’s why.